8-K: Cryo-Cell Extends Credit, Adjusts Loan Terms

Cryo-Cell International amended its credit agreement with Susser Bank, extending maturity dates for its revolving credit and term loans while adjusting credit limits and interest margins.

Summary

• Cryo-Cell International, Inc. entered into a Fifth Amendment to its Credit Agreement with Susser Bank on October 18, 2025.
• The maturity date of the Revolving Credit Facility (RCF) Note was extended to October 18, 2027, from its previous extension to October 18, 2025.
• The Term Note's maturity date was slightly extended to July 29, 2032, from July 18, 2032.
• The revolving credit commitment was revised downwards to $8,000,000 from the original $10,000,000.
• The Company's wholly-owned subsidiary, Celle Corp., became a guarantor under the Credit Agreement and executed a Security Agreement.
• Applicable interest margins for Revolving Credit Loans were reduced: Base Rate margin to 3.75% (from 4.25%) and Monthly SOFR margin to 2.75% (from 3.25%).
• Applicable interest margins for Term Loans remained unchanged: Base Rate margin at 4.25% and Monthly SOFR margin at 3.25%.
• A commitment fee of 0.25% was also specified.

Sentiment

Score: 5

Explanation: The extension of loan maturity dates provides stability, but the reduction in the revolving credit facility limit and the requirement for a subsidiary to act as a guarantor indicate a less favorable credit environment or increased perceived risk by the lender. The reduced RCF margins are a small positive.

Positives

• Maturity date for the Revolving Credit Facility (RCF) Note extended by two years to October 18, 2027, providing longer-term liquidity.
• Maturity date for the Term Note slightly extended to July 29, 2032.
• Applicable interest margins for Revolving Credit Loans were reduced, potentially lowering borrowing costs for the RCF.

Negatives

• Revolving credit commitment reduced from $10,000,000 to $8,000,000, decreasing available liquidity.
• Celle Corp., a wholly-owned subsidiary, became a guarantor under the Credit Agreement and executed a Security Agreement, increasing the collateral backing the loans.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the extended maturity dates of the loans.

Industry Context

This amendment reflects a routine corporate finance activity where companies adjust their debt facilities based on ongoing needs and lender assessments. The extension of maturity dates provides financial flexibility, while the reduction in the RCF limit and addition of a guarantor might suggest a more cautious lending environment or a re-evaluation of the company's credit profile by Susser Bank.

Stakeholder Impact

• Shareholders: The extension of debt maturities provides financial stability and reduces immediate refinancing risk, which is generally positive. However, the reduced RCF limit and increased collateral (guarantor) could be seen as a slight negative, potentially limiting future operational flexibility or indicating increased lender caution.
• Creditors (Susser Bank): The addition of Celle Corp. as a guarantor and the Security Agreement enhance the collateral backing the loans, improving the lender's security position.

Next Steps

• The Fifth Amendment to the Credit Agreement will be filed with the Company's next annual report on Form 10-K.

Key Dates

Recommendation

While the extension of debt maturities provides crucial financial stability and removes immediate refinancing pressure, the reduction in the revolving credit facility and the requirement for a subsidiary to act as a guarantor suggest a more cautious stance from the lender. This indicates a mixed financial signal. Investors should hold and monitor future financial performance and any further updates on liquidity or operational efficiency.

Keywords

Cryo-Cell International, CCEL, Credit Agreement, Susser Bank, Revolving Credit Facility, Term Loan, Loan Extension, Credit Limit, Interest Rates, Corporate Finance, SEC Filing, 8-K, Celle Corp, Guarantor, Financial Obligation